Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has…
| Price | $160.90 |
|---|---|
| Market cap | $10.02B |
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
| 52-week range | 23.3-163.7 |
| Beta | 2.22 |
Explore TWST's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.